Healthway Medical Corporation Ltd
SGX:5NG
Healthway Medical Corporation Ltd
SGX:5NG
Price:
0.047
SGD
Market Closed
Market Cap:
S$213.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Healthway Medical Corporation Ltd
SGX:5NG
|
SG |
|
Andes Technology Corp
TWSE:6533
|
TW |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
G
|
Gielda Papierow Wartosciowych w Warszawie SA
WSE:GPW
|
PL |
Income Statement
Earnings Waterfall
Healthway Medical Corporation Ltd
Healthway Medical Corporation Ltd
Income Statement
Healthway Medical Corporation Ltd
Healthway Medical Corporation Ltd
Currency: SGD
| Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
79
N/A
|
78
-1%
|
78
-1%
|
78
+0%
|
78
+1%
|
82
+4%
|
82
+0%
|
82
0%
|
82
+1%
|
81
-2%
|
82
+2%
|
83
+1%
|
84
+1%
|
86
+2%
|
87
+2%
|
91
+4%
|
92
+2%
|
94
+2%
|
95
+1%
|
94
-1%
|
97
+2%
|
97
0%
|
95
-2%
|
97
+2%
|
99
+2%
|
105
+6%
|
110
+5%
|
113
+3%
|
114
+0%
|
113
-1%
|
111
-1%
|
111
0%
|
112
+2%
|
114
+2%
|
105
-8%
|
97
-7%
|
118
+21%
|
140
+18%
|
154
+10%
|
160
+4%
|
161
+1%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(17)
|
(17)
|
(18)
|
(18)
|
(18)
|
(18)
|
(18)
|
(18)
|
(19)
|
(19)
|
(19)
|
(20)
|
(19)
|
(19)
|
(19)
|
(19)
|
(20)
|
(21)
|
(22)
|
(22)
|
(22)
|
(22)
|
(22)
|
(22)
|
(22)
|
(20)
|
(19)
|
(23)
|
(27)
|
(28)
|
(28)
|
(27)
|
|
| Gross Profit |
63
N/A
|
62
-1%
|
62
0%
|
62
-1%
|
62
+0%
|
65
+5%
|
65
0%
|
65
0%
|
66
+2%
|
64
-3%
|
65
+2%
|
66
+0%
|
66
+1%
|
68
+2%
|
69
+2%
|
72
+5%
|
74
+2%
|
75
+2%
|
76
+1%
|
75
-1%
|
77
+3%
|
77
+0%
|
77
-1%
|
79
+3%
|
80
+2%
|
85
+6%
|
89
+5%
|
92
+3%
|
92
+1%
|
91
-1%
|
90
-2%
|
89
0%
|
91
+2%
|
92
+2%
|
85
-8%
|
78
-7%
|
95
+21%
|
113
+19%
|
125
+11%
|
132
+6%
|
134
+1%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(57)
|
(67)
|
(127)
|
(130)
|
(130)
|
(72)
|
(69)
|
(43)
|
(35)
|
(81)
|
(33)
|
(56)
|
(56)
|
(70)
|
(55)
|
(57)
|
(72)
|
(72)
|
(76)
|
(77)
|
(76)
|
(114)
|
(120)
|
(124)
|
(127)
|
(91)
|
(121)
|
(122)
|
(97)
|
(97)
|
(96)
|
(96)
|
(96)
|
(94)
|
(85)
|
(75)
|
(85)
|
(102)
|
(111)
|
(117)
|
(122)
|
|
| Selling, General & Administrative |
(47)
|
(60)
|
(61)
|
(63)
|
(63)
|
(64)
|
(63)
|
(63)
|
(64)
|
(73)
|
(52)
|
(53)
|
(54)
|
(70)
|
(71)
|
(73)
|
(74)
|
(72)
|
(73)
|
(72)
|
(74)
|
(108)
|
(110)
|
(116)
|
(120)
|
(83)
|
(87)
|
(89)
|
(89)
|
(86)
|
(83)
|
(81)
|
(78)
|
(76)
|
(72)
|
(61)
|
(66)
|
(84)
|
(92)
|
(94)
|
(98)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(4)
|
(7)
|
(9)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(13)
|
(15)
|
|
| Other Operating Expenses |
(9)
|
(5)
|
(65)
|
(65)
|
(65)
|
(6)
|
(4)
|
21
|
31
|
(6)
|
20
|
(1)
|
(0)
|
2
|
18
|
17
|
4
|
1
|
(2)
|
(4)
|
(1)
|
(5)
|
(8)
|
(6)
|
(5)
|
(7)
|
(31)
|
(31)
|
(6)
|
(9)
|
(9)
|
(9)
|
(9)
|
(7)
|
(2)
|
(3)
|
(8)
|
(7)
|
(7)
|
(10)
|
(9)
|
|
| Operating Income |
6
N/A
|
(4)
N/A
|
(65)
-1 426%
|
(68)
-5%
|
(68)
+1%
|
(7)
+90%
|
(4)
+43%
|
21
N/A
|
31
+46%
|
(17)
N/A
|
32
N/A
|
10
-69%
|
10
+1%
|
(2)
N/A
|
14
N/A
|
15
+10%
|
2
-89%
|
3
+82%
|
0
-88%
|
(2)
N/A
|
1
N/A
|
(37)
N/A
|
(43)
-18%
|
(45)
-4%
|
(47)
-5%
|
(6)
+86%
|
(32)
-388%
|
(30)
+4%
|
(5)
+84%
|
(6)
-21%
|
(7)
-10%
|
(7)
-7%
|
(5)
+22%
|
(2)
+61%
|
(0)
+76%
|
4
N/A
|
10
+170%
|
11
+14%
|
15
+31%
|
16
+7%
|
12
-23%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
43
|
(1)
|
(1)
|
(0)
|
12
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Non-Reccuring Items |
0
|
(58)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
(25)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
1
|
4
|
9
|
9
|
16
|
13
|
8
|
8
|
5
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
5
N/A
|
(63)
N/A
|
(62)
+1%
|
(61)
+2%
|
(61)
+0%
|
8
N/A
|
7
-9%
|
28
+274%
|
37
+33%
|
31
-16%
|
31
-1%
|
9
-70%
|
10
+8%
|
10
+1%
|
13
+29%
|
14
+11%
|
1
-96%
|
3
+418%
|
(1)
N/A
|
(3)
-329%
|
(1)
+85%
|
(44)
-8 585%
|
(45)
-2%
|
(48)
-5%
|
(50)
-6%
|
(34)
+32%
|
(34)
+1%
|
(31)
+7%
|
(30)
+3%
|
(6)
+80%
|
(7)
-20%
|
(8)
-10%
|
(7)
+15%
|
(3)
+55%
|
(2)
+40%
|
3
N/A
|
9
+242%
|
10
+19%
|
13
+31%
|
14
+6%
|
10
-31%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
0
|
(1)
|
(2)
|
(1)
|
|
| Income from Continuing Operations |
4
|
(63)
|
(63)
|
(62)
|
(62)
|
8
|
7
|
28
|
37
|
31
|
30
|
8
|
9
|
10
|
12
|
13
|
(0)
|
2
|
(1)
|
(3)
|
(0)
|
(44)
|
(45)
|
(48)
|
(51)
|
(35)
|
(34)
|
(31)
|
(30)
|
(6)
|
(7)
|
(8)
|
(7)
|
(3)
|
(2)
|
3
|
9
|
11
|
13
|
12
|
9
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Income (Common) |
4
N/A
|
(63)
N/A
|
(63)
+1%
|
(62)
+1%
|
(62)
+0%
|
8
N/A
|
7
-4%
|
28
+290%
|
37
+32%
|
31
-18%
|
30
0%
|
8
-74%
|
9
+8%
|
10
+15%
|
12
+21%
|
13
+13%
|
(0)
N/A
|
2
N/A
|
(1)
N/A
|
(3)
-159%
|
(0)
+94%
|
(44)
-23 115%
|
(45)
-2%
|
(48)
-6%
|
(51)
-6%
|
(35)
+31%
|
(34)
+2%
|
(31)
+8%
|
(30)
+4%
|
(6)
+81%
|
(7)
-20%
|
(8)
-11%
|
(7)
+15%
|
(3)
+56%
|
(2)
+41%
|
3
N/A
|
9
+185%
|
11
+17%
|
13
+20%
|
13
-3%
|
9
-31%
|
|
| EPS (Diluted) |
0
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.03
N/A
|
0
N/A
|
0
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
